A 44-year-old Caucasian male complains of carpopedal spasms, peri-oral numbness, and paresthesias of the hands and feet. His wife also mentions that he had a seizure not too long ago. His past surgical history is significant for total thyroidectomy due to papillary thyroid carcinoma. They then realized all of the symptoms occurred after the surgery. Which of the following would be present in this patient?
A 41-year-old man presents to urgent care with a 1-week history of severe diarrhea. He says that he has been having watery stools every 2-3 hours. The stools do not contain blood and do not float. On presentation, he is observed to have significant facial flushing, and laboratory tests reveal the following: Serum: Na+: 137 mEq/L K+: 2.7 mEq/L Cl-: 113 mEq/L HCO3-: 14 mEq/L A computed tomography scan reveals a small intra-abdominal mass. Staining of this mass would most likely reveal production of which of the following?
A 67-year-old woman presents to the Emergency Department complaining of weakness and fatigue. She says she caught a “stomach bug” and has not been able to eat anything without vomiting for three days. Past medical history is significant for hyperlipidemia. She takes atorvastatin and a multivitamin daily, except for the last two days due to nausea. Today her heart rate is 106/min, respiratory rate is 16/min, temperature is 37.6°C (99.7°F) and blood pressure of 110/70 mm Hg. On physical examination, her oral mucosa is dry and she looks pale and uncomfortable. She is admitted for care and administered ondansetron. An intravenous infusion of normal saline is also initiated. An arterial blood gas is collected. Which of the following results is expected to be seen in this patient?
A 22-year-old woman presents to the physician due to lightheadedness. Earlier in the day, she had her first job interview since graduating from college 3 months ago. While waiting outside the interviewer’s office, she began to feel nervous and started breathing really fast. She then felt as if she was going to faint. She excused herself from the interview, and requested a friend to drive her to the clinic. Which of the following is responsible for her symptoms?
A 54-year-old man presents with 3 days of non-bloody and non-bilious emesis every time he eats or drinks. He has become progressively weaker and the emesis has not improved. He denies diarrhea, fever, or chills and thinks his symptoms may be related to a recent event that involved sampling many different foods. His temperature is 97.5°F (36.4°C), blood pressure is 133/82 mmHg, pulse is 105/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam is notable for a weak appearing man with dry mucous membranes. His abdomen is nontender. Which of the following laboratory changes would most likely be seen in this patient?
A 56-year-old woman with a longstanding history of gastroesophageal reflux presents for follow-up evaluation of endoscopically confirmed gastric and duodenal ulcers. Her symptoms have been unresponsive to proton pump inhibitors and histamine receptor antagonists in the past. Results for H. pylori infection are still pending. Which of the following changes is expected in the patient's duodenum, given her peptic ulcer disease?
A healthy 20-year-old male college student attempts to climb Mount Everest and travels to the Tibetan plateau by plane. Upon landing, he feels increasingly dizzy and fatigued. He notices that he is breathing faster than usual. What is the initial stimulus for the most likely acid-base disorder?
A 32-year-old man is brought to the emergency department after he was found unresponsive on the street. Upon admission, he is lethargic and cyanotic with small, symmetrical pinpoint pupils. The following vital signs were registered: blood pressure of 100/60 mm Hg, heart rate of 70/min, respiratory rate of 8/min, and a body temperature of 36.0°C (96.8°F). While being assessed and resuscitated, a sample for arterial blood gas (ABG) analysis was taken, in addition to the following biochemistry tests: Laboratory test Serum Na+ 138 mEq/L Serum Cl- 101 mEq/L Serum K+ 4.0 mEq/L Serum creatinine (SCr) 0.58 mg/dL Which of the following values would you most likely expect to see in this patient’s ABG results?
A 67-year-old man presents to his primary care physician because of weak urine stream, and increasing difficulty in initiating and stopping urination. He also reports of mild generalized body aches and weakness during the day. The past medical history includes diabetes mellitus type 2 for 35 years and essential hypertension for 19 years. The medication list includes metformin, vildagliptin, and enalapril. The vital signs include: temperature 36.7°C (98.1°F), blood pressure 151/82 mm Hg, and pulse 88/min. The physical examination is remarkable for markedly enlarged, firm prostate without nodules. The laboratory test results are as follows: Serum sodium 142 mEq/L Serum potassium 5.7 mEq/L Serum chloride 115 mEq/L Serum bicarbonate 17 mEq/L Serum creatinine 0.9 mg/dL Arterial pH 7.31 Urine pH 5.3 Urine sodium 59 mEq/L Urine potassium 6.2 mEq/L Urine chloride 65 mEq/L Which of the following most likely explains the patient’s findings?
A 32-year-old woman is admitted to the emergency department for 36 hours of intense left-sided back pain that extends into her left groin. She reports that the pain started a day after a charitable 5 km (3.1 mi) marathon. The past medical history is relevant for multiple complaints of eye dryness and dry mouth. Physical examination is unremarkable, except for intense left-sided costovertebral pain. The results from laboratory tests are shown. Laboratory test Result Serum Na+ 137 Serum Cl- 110 Serum K+ 3.0 Serum creatinine (SCr) 0.82 Arterial blood gas Result pH 7.28 pO2 98 mm Hg pCO2 28.5 mm Hg SaO2% 98% HCO3- 15 mm Hg Which of the following explains this patient’s condition?
Explanation: ***Chvostek sign, QT prolongation, decreased PTH, decreased serum calcium, increased serum phosphate*** - The patient's symptoms of carpopedal spasms, peri-oral numbness, paresthesias, and seizures following a **total thyroidectomy** are classic signs of **hypocalcemia** due to **hypoparathyroidism**. This would lead to a **decreased PTH** level, which in turn causes **decreased serum calcium** and **increased serum phosphate** due to impaired renal phosphate excretion. - **Hypocalcemia** characteristically causes **QT prolongation** on EKG and can manifest as the **Chvostek sign** (facial muscle twitching when tapping the facial nerve). *Chvostek sign, QT prolongation, increased PTH, decreased serum calcium, decreased serum phosphate* - This option incorrectly states **increased PTH**. The symptoms are due to iatrogenic hypoparathyroidism following thyroidectomy, which results in **decreased PTH** production. - While **decreased serum calcium** and **Chvostek sign** are consistent, the PTH and phosphate levels described here are characteristic of **pseudohypoparathyroidism** or vitamin D deficiency, not post-surgical hypoparathyroidism. *Chvostek sign, QT shortening, increased PTH, increased serum calcium, increased serum phosphate* - **QT shortening** is typically associated with **hypercalcemia**, not hypocalcemia, and the patient's symptoms are indicative of hypocalcemia. - **Increased serum calcium** and **increased PTH** would point towards primary hyperparathyroidism, which is the opposite of the clinical picture presented. *Chvostek sign, QT shortening, decreased PTH, decreased serum calcium, increased serum phosphate* - This option incorrectly states **QT shortening**. **Hypocalcemia** is known to cause **QT prolongation**, not shortening. - While other findings like **decreased PTH**, **decreased serum calcium**, and **increased serum phosphate** are consistent with post-thyroidectomy hypoparathyroidism, the erroneous QT interval change makes this option incorrect. *Chvostek sign, QT prolongation, decreased PTH, increased serum calcium, decreased serum phosphate* - This option incorrectly states **increased serum calcium**. The symptoms of carpopedal spasms and paresthesias are classic manifestations of **hypocalcemia**. - Additionally, **decreased serum phosphate** in the setting of decreased PTH would be unusual; **hypoparathyroidism** typically leads to **hyperphosphatemia** due to reduced renal phosphate excretion.
Explanation: ***Vasoactive intestinal peptide*** - The patient's presentation with **severe watery diarrhea**, **hypokalemia**, **metabolic acidosis** (low HCO3-), and **facial flushing** in the presence of an **intra-abdominal mass** is highly indicative of a **VIPoma**. - VIPomas are neuroendocrine tumors that secrete large amounts of **vasoactive intestinal peptide (VIP)**, which stimulates intestinal fluid secretion and inhibits absorption, leading to characteristic symptoms. *Insulin* - **Insulinomas** typically cause symptoms related to **hypoglycemia** (e.g., sweating, palpitations, confusion), which are not described in this patient. - While insulinomas can be associated with an intra-abdominal mass, the patient's symptoms are inconsistent with excessive insulin production. *Glucagon* - **Glucagonomas** classically present with a syndrome including **necrolytic migratory erythema**, **diabetes mellitus**, and weight loss, along with diarrhea in some cases. - The distinct skin rash and hyperglycemia are absent in this patient's presentation. *Somatostatin* - **Somatostatinomas** are often associated with a triad of **diabetes mellitus**, **cholelithiasis**, and **steatorrhea**, and sometimes hypochlorhydria. - The patient's symptoms of severe watery diarrhea and flushing are not typical of somatostatin overproduction. *Gastrin* - **Gastrinomas** (Zollinger-Ellison syndrome) cause severe **peptic ulcer disease** due to excessive gastric acid secretion, often leading to abdominal pain and chronic diarrhea. - While diarrhea can occur, the prominent hypokalemia, metabolic acidosis, and flushing point away from a gastrinoma as the primary diagnosis.
Explanation: ***pH: 7.48, pCO2: 44 mm Hg, HCO3-: 29 mEq/L*** - The patient's prolonged vomiting leads to a loss of **gastric acid (HCl)**, resulting in an increase in serum bicarbonate (**metabolic alkalosis**), which is reflected by the elevated pH (7.48) and HCO3- (29 mEq/L). - The pCO2 (44 mm Hg) is slightly elevated above normal (40 mm Hg), indicating the expected **respiratory compensation** for metabolic alkalosis (hypoventilation to retain CO2 and normalize pH). *pH: 7.49, pCO2: 33 mm Hg, HCO3-: 18 mEq/L* - This option indicates a **respiratory alkalosis** with partial metabolic compensation, characterized by a high pH, low pCO2, and low HCO3-. - The patient's condition of prolonged vomiting would not lead to an acidic (low HCO3-) or hyperventilatory (low pCO2) state. *pH: 7.31, pCO2: 62 mm Hg, HCO3-: 27 mEq/L* - This result suggests **respiratory acidosis** with partial metabolic compensation, indicated by a low pH, high pCO2, and slightly elevated HCO3-. - Vomiting primarily causes metabolic alkalosis due to loss of acid, not respiratory acidosis. *pH: 7.30, pCO2: 36 mm Hg, HCO3-: 17 mEq/L* - This option points to **metabolic acidosis** with a low pH and low HCO3-, and a near-normal pCO2, indicating minimal respiratory compensation. - While dehydration can occur, the primary acid-base disturbance from prolonged vomiting is a loss of acid, leading to alkalosis, not acidosis. *pH: 7.36, pCO2: 42 mm Hg, HCO3-: 22 mEq/L* - These values fall within the **normal range**, implying no significant acid-base disturbance. - The patient's symptoms of prolonged vomiting and dehydration would inevitably lead to an acid-base imbalance.
Explanation: ***Decreased arterial pCO2*** - The patient's **lightheadedness** and sensation of fainting, coupled with **rapid breathing** during a stressful situation, are classic signs of **hyperventilation syndrome**. - Rapid breathing leads to excessive elimination of carbon dioxide, causing **respiratory alkalosis** and a decrease in arterial pCO2. - Low pCO2 causes **cerebral vasoconstriction**, reducing cerebral blood flow and leading to **lightheadedness and presyncope**. *Increased arterial pO2* - While hyperventilation can slightly increase arterial pO2, this increase generally has **minimal physiological impact** and does not cause lightheadedness or syncope. - The primary physiological consequence in this scenario is due to the **alteration of CO2 levels**, not O2. *Decreased arterial pH* - This symptom describes **acidosis**, which would typically result from conditions like hypoventilation (leading to CO2 retention) or metabolic disturbances. - The patient's rapid breathing indicates **respiratory alkalosis**, which involves an **increased arterial pH**, not decreased. *Increased plasma lactic acid* - While stress can induce some **anaerobic metabolism**, leading to lactic acid production, the primary and most immediate cause of symptoms in acute hyperventilation is not lactic acidosis. - **Lactic acidosis** is associated with more severe metabolic disturbances or sustained intense physical exertion, not acute anxiety-related hyperventilation. *Vagus nerve stimulation* - **Vagal stimulation** can lead to symptoms like lightheadedness and fainting by causing **bradycardia** and **vasodilation** (vasovagal syncope). - However, this is typically associated with specific triggers and leads to a direct cardiovascular response rather than the **rapid breathing** pattern seen in this patient, which points to a respiratory cause.
Explanation: ***Metabolic alkalosis and hypokalemia*** - Persistent **vomiting** leads to the loss of **gastric acid** (HCl) and **potassium**, resulting in **metabolic alkalosis** and **hypokalemia**. The loss of HCl directly removes acid from the body, and the subsequent renal compensation to conserve volume often exacerbates potassium loss. - The patient's presentation with **dry mucous membranes**, increased heart rate (pulse 105/min), and persistent non-bloody, non-bilious emesis suggests significant volume depletion and electrolyte imbalances consistent with prolonged vomiting. *Metabolic alkalosis and hyperkalemia* - While metabolic alkalosis is expected due to gastric acid loss from vomiting, **hyperkalemia** is unlikely. Vomiting typically causes **hypokalemia** due to direct potassium loss and renal compensation mechanisms. - The body attempts to compensate for volume depletion, leading to increased activity of the **renin-angiotensin-aldosterone system**, which promotes potassium excretion in the urine. *Non-anion gap metabolic acidosis and hypokalemia* - **Metabolic acidosis** is characterized by a decrease in blood pH and bicarbonate; however, profuse vomiting of gastric contents primarily leads to **alkalosis** due to the loss of hydrogen ions. - **Non-anion gap metabolic acidosis** is usually seen in conditions involving bicarbonate loss from the kidneys or gut (e.g., diarrhea, renal tubular acidosis), not vomiting. *Respiratory acidosis and hyperkalemia* - **Respiratory acidosis** results from hypoventilation, leading to an increase in blood CO2, which is not suggested by the patient's normal respiratory rate and oxygen saturation. - Profuse vomiting causes a loss of gastric acid and can lead to compensatory **hypoventilation** to retain CO2 (acid), but this is a secondary response to metabolic alkalosis, and primary respiratory acidosis is not the underlying issue. *Anion gap metabolic acidosis and hypokalemia* - **Anion gap metabolic acidosis** typically occurs with the accumulation of unmeasured acids (e.g., lactic acidosis, ketoacidosis, renal failure, poisoning), which is not indicated by the patient's symptoms. - While **hypokalemia** is consistent with vomiting, the primary acid-base disturbance from prolonged emesis is metabolic alkalosis, not acidosis.
Explanation: ***Hyperplasia of submucosal bicarbonate-secreting glands*** - The duodenum attempts to protect itself from excessive acid due to gastric and duodenal ulcers by increasing **bicarbonate secretion**. - **Bicarbonate-secreting glands (Brunner's glands)** in the duodenum undergo hyperplasia to neutralize the acidic chyme entering from the stomach, especially when peptic ulcers are present. *Proliferation of secretin-releasing S cells* - While secretin is released in response to acid in the duodenum and stimulates bicarbonate secretion, **S cell proliferation** itself is not a primary expected histological change in peptic ulcer disease. - The main adaptation is the increased functional capacity of bicarbonate-secreting glands, rather than an increase in the number of secretin-producing cells. *Increased secretions from crypts of Lieberkühn* - The **crypts of Lieberkühn** are involved in fluid and electrolyte secretion, as well as cell turnover in the small intestine. - While they contribute to the intestinal environment, their primary role is not to counteract the high acid load seen in peptic ulcer disease, and their secretions are not predominantly bicarbonate-rich. *Increased glucose-dependent insulinotropic peptide (GIP) release from K cells* - **GIP** is released from K cells in response to glucose and fat in the duodenum, stimulating insulin secretion. - Its release is primarily linked to nutrient absorption and glucose homeostasis, not a direct compensatory mechanism for acid-induced peptic ulcer disease. *Expansion of gastrointestinal lymphoid tissue* - **Gastrointestinal lymphoid tissue (GALT)**, such as Peyer's patches, is involved in immune surveillance in the intestine. - While chronic inflammation can lead to lymphoid hyperplasia, it is not a direct or primary protective mechanism against acid per se in peptic ulcer disease; rather, it indicates an immune response, which might occur with H. pylori infection but isn't the duodenum's main anti-acid adaptation.
Explanation: ***Decreased partial pressure of alveolar oxygen*** - Upon rapid ascent to high altitude (like the Tibetan plateau), the ambient atmospheric pressure decreases, leading to a significant drop in the **partial pressure of inspired oxygen (PiO2)**. - This reduction in PiO2 directly causes a decrease in the **partial pressure of alveolar oxygen (PAO2)**, which is the primary stimulus for activation of peripheral chemoreceptors, leading to hyperventilation and a respiratory alkalosis. *Undiagnosed atrial septal defect* - An atrial septal defect (ASD) would cause a **left-to-right shunt** in a healthy young adult, not typically presenting with acute dizziness and fatigue immediately upon high-altitude exposure. - While an ASD can lead to cyanosis and dyspnea with exertion, it would not be the initial stimulus for the observed hyperventilation response to high altitude. *Increasing arterial partial pressure of carbon dioxide* - An increasing **arterial partial pressure of carbon dioxide (PaCO2)** would stimulate central chemoreceptors and increase ventilation, but it is not the initial trigger in this scenario. - In response to **hypoxia** at high altitude, the body *hyperventilates*, which would lead to a *decrease* in PaCO2, not an increase. *Worsened diffusion limitation of oxygen* - **Diffusion limitation** of oxygen refers to impaired gas exchange across the alveolar-capillary membrane, usually due to conditions like fibrosis or edema. - While gas exchange can be affected at extreme altitudes, it is not the primary initial physiological trigger for the body's acute response (hyperventilation) in a healthy individual. *Hypoxic pulmonary vasodilation* - **Hypoxic pulmonary vasoconstriction** (not vasodilation) is a physiological response in the lungs where pulmonary arterioles constrict in areas of low oxygen, redirecting blood flow to better-ventilated areas. - This mechanism aims to optimize V/Q matching and is a *response* to hypoxia, not the initial stimulus for the systemic acid-base derangement leading to symptoms like dizziness and increased breathing rate.
Explanation: ***pH: decreased, HCO3- : increased, Pco2: increased*** - The patient's **depressed respiratory rate** (8/min) indicates severe hypoventilation, leading to **CO2 retention** and subsequent **respiratory acidosis** (decreased pH, increased PaCO2). - In **acute respiratory acidosis**, the body initiates immediate buffering, causing a **mild increase in HCO3-** (approximately 1 mEq/L per 10 mmHg rise in PaCO2). Over 3-5 days, renal compensation leads to more significant HCO3- retention, but in this acute presentation, some HCO3- elevation is expected from acute buffering mechanisms. - The **decreased pH** indicates that compensation is incomplete, which is typical in the acute setting. *pH: increased, HCO3- : decreased, Pco2: decreased* - This pattern is characteristic of **respiratory alkalosis** (increased pH, decreased PaCO2) with metabolic compensation (decreased HCO3-), which would occur in hyperventilation, opposite to the patient's presentation. - The patient's **slow respiratory rate** of 8/min directly contradicts the finding of decreased PaCO2. *pH: decreased, HCO3- : decreased, Pco2: decreased* - This suggests a **metabolic acidosis** (decreased pH, decreased HCO3-) with respiratory compensation (decreased PaCO2), typically seen in conditions like DKA or lactic acidosis. - Although the pH is decreased, the patient's severe bradypnea (RR 8/min) indicates increased CO2 retention, not decreased CO2. *pH: increased, HCO3- : increased, Pco2: increased* - This combination of findings is indicative of **metabolic alkalosis** (increased pH, increased HCO3-) with respiratory compensation (increased PaCO2). - This is inconsistent with the patient's pinpoint pupils, cyanosis, and **severe bradypnea**, which are classic signs of opioid overdose causing respiratory depression and acidosis, not alkalosis. *pH: normal, HCO3- : increased, Pco2: increased* - A normal pH despite increased HCO3- and PaCO2 indicates **fully compensated respiratory acidosis**, which requires days of renal compensation to develop. - In this **acute, severe drug overdose** with profound respiratory depression, the body would not have sufficient time to achieve full compensation, thus the pH would remain low.
Explanation: ***Type 4 renal tubular acidosis*** - The patient presents with **hyperkalemia** (serum potassium 5.7 mEq/L) and **non-anion gap metabolic acidosis** (serum bicarbonate 17 mEq/L, pH 7.31) with a relatively low urine pH (5.3). This combination is characteristic of **Type 4 RTA**, which often results from **hypoaldosteronism** or renal **aldosterone resistance**. - His long-standing **diabetes mellitus** can cause damage to the **juxtaglomerular apparatus** or autonomic neuropathy, impairing renin and ultimately aldosterone secretion. Additionally, **enalapril** (an ACE inhibitor) contributes to reduced aldosterone levels, further exacerbating the condition. *Fanconi syndrome* - This syndrome is characterized by a generalized defect in the **proximal tubule**, leading to the loss of **glucose**, **amino acids**, **phosphate**, and **bicarbonate** in the urine. - While it causes RTA, it typically presents with **hypokalemia** due to increased potassium excretion, which is contrary to this patient's **hyperkalemia**. *Type 1 renal tubular acidosis* - This type involves a defect in **distal tubule** hydrogen ion secretion, resulting in **metabolic acidosis** with a **high urine pH** (>5.5) despite systemic acidosis. - Patients with Type 1 RTA typically present with **hypokalemia** due to increased potassium excretion, unlike the hyperkalemia seen in this patient. *Type 2 renal tubular acidosis* - This condition involves impaired **bicarbonate reabsorption** in the **proximal tubule**. Initially, it leads to metabolic acidosis with a high urine pH. - However, once the filtered bicarbonate load falls below the compromised reabsorptive capacity, the urine pH can become acidic. Like Type 1 RTA, it is typically associated with **hypokalemia**. *End-stage renal disease* - While ESRD can cause metabolic acidosis and hyperkalemia due to severe reduction in GFR, the patient's **creatinine** (0.9 mg/dL) is within the normal range, indicating preserved renal function. - Also, ESRD typically involves much broader complications of uremia beyond just electrolyte imbalances, which are not described here.
Explanation: ***Decreased renal excretion of hydrogen ions (H+)*** - The patient presents with **metabolic acidosis** (pH 7.28, HCO3- 15 mEq/L) with **respiratory compensation** (pCO2 28.5 mm Hg). The anion gap is **normal** (Na+ - (Cl- + HCO3-) = 137 - (110 + 15) = **12 mEq/L**), indicating a **non-anion gap metabolic acidosis**. - The history of **dry eyes and dry mouth** strongly suggests **Sjögren syndrome**, which is commonly associated with **Type 1 (distal) renal tubular acidosis**. - In **Type 1 RTA**, the distal tubule alpha-intercalated cells cannot adequately secrete H+ ions, leading to metabolic acidosis with **inability to acidify urine** (urine pH > 5.5). Associated findings include **hypokalemia** (K+ 3.0), **nephrolithiasis** (calcium phosphate stones due to alkaline urine), and hypercalciuria. - The left-sided flank pain radiating to the groin is consistent with **nephrolithiasis**, a common complication of Type 1 RTA. *Carbonic acid accumulation* - **Carbonic acid accumulation** indicates **respiratory acidosis** with elevated pCO2, which is not present here. - The patient has a **low pCO2 (28.5 mm Hg)**, representing appropriate **respiratory compensation** for the primary metabolic acidosis. *Decreased bicarbonate renal absorption* - **Decreased bicarbonate renal absorption** characterizes **Type 2 (proximal) RTA**. - While Type 2 RTA also causes non-anion gap metabolic acidosis, it is **not typically associated with Sjögren syndrome** and would present with different features (glycosuria, aminoaciduria, phosphaturia as part of Fanconi syndrome). - Type 2 RTA can acidify urine to pH < 5.5 when serum HCO3- is low, unlike Type 1 RTA. *Decreased synthesis of ammonia (NH3)* - **Decreased ammonia synthesis** is characteristic of **Type 4 RTA** or severe chronic kidney disease. - Type 4 RTA presents with **hyperkalemia** (due to hypoaldosteronism), not the hypokalemia seen in this patient. - The normal serum creatinine (0.82 mg/dL) rules out significant renal failure. *Decreased excretion of nonvolatile acids* - **Decreased excretion of nonvolatile acids** would cause **elevated anion gap metabolic acidosis** (e.g., lactic acidosis, ketoacidosis, or advanced renal failure with accumulation of organic acids). - This patient has a **normal anion gap (12 mEq/L)** and **normal renal function** (creatinine 0.82 mg/dL), making this mechanism unlikely. - The clinical context of Sjögren syndrome with dry eyes/mouth points specifically to distal RTA.
Explanation: ***Inability of the distal tubule to secrete H+*** - The patient presents with **non-anion gap metabolic acidosis** (pH 7.28, HCO3- 12 mEq/L, anion gap = 138 - (115 + 12) = 11), **hypokalemia** (K+ 3.1 mEq/L), and **inappropriately alkaline urine** (pH 6.9). These findings are classic for **distal (Type 1) renal tubular acidosis (RTA)**, where the distal tubules cannot excrete H+ adequately, leading to systemic acidosis. - The symptoms of **poor feeding, irritability, vomiting**, and **poor growth** are common manifestations of chronic acidosis in infants. *Deficiency of ornithine transcarbamylase* - This urea cycle disorder would lead to **hyperammonemia** (ammonia >50 μmol/L), which is not present here (ammonia 23 μmol/L). - While it can cause metabolic acidosis due to accumulation of organic acids in severe cases, the primary biochemical derangement is hyperammonemia, and the findings of an alkaline urine pH with metabolic acidosis are not typical. *Impaired metabolism of branched-chain amino acids* - This condition, known as **Maple Syrup Urine Disease**, primarily presents with a characteristic sweet odor to the urine and neurological deterioration due to the accumulation of branched-chain amino acids and their ketoacids. - It would typically cause a significant **anion gap metabolic acidosis** and not an alkaline urine pH. *Impaired CFTR gene function* - This describes **Cystic Fibrosis**, which primarily affects exocrine glands, leading to symptoms like **malabsorption**, recurrent pulmonary infections, and meconium ileus in neonates. - It does not typically cause the specific electrolyte and acid-base disturbances seen here (non-anion gap metabolic acidosis with hypokalemia and alkaline urine). *Deficiency of 21-hydroxylase* - This enzyme deficiency causes **Congenital Adrenal Hyperplasia (CAH)**. The most common form leads to **salt-wasting crises** with hyponatremia and hyperkalemia. - It would not typically present with hypokalemia and non-anion gap metabolic acidosis with alkaline urine pH.
Explanation: ***Living at high altitude*** - Chronic exposure to **high altitude** leads to sustained **hypoxia**, which stimulates **hyperventilation** as a compensatory mechanism. - This persistent hyperventilation causes a **respiratory alkalosis** (high pH, low pCO2) and a compensatory **metabolic acidosis** (low HCO3-) to normalize pH, mimicking the presented metabolic panel. *Diarrheal disease* - Severe **diarrhea** leads to the loss of bicarbonate from the gastrointestinal tract, causing a **non-anion gap metabolic acidosis**. - This would present with a **low pH**, **low HCO3-**, and a **compensatory drop in pCO2**, not a respiratory alkalosis with a high pH. *Loop diuretic abuse* - Chronic abuse of **loop diuretics** can cause **metabolic alkalosis** due to increased renal excretion of hydrogen ions and potassium, leading to volume contraction. - This would typically present with a **high pH**, high HCO3-, and a compensatory rise in pCO2, which is different from the given values. *Ingestion of metformin* - **Metformin** can cause **lactic acidosis** (a type of high anion gap metabolic acidosis), especially in patients with renal impairment. - This would manifest as a **low pH**, **low HCO3-**, and a **compensatory decrease in pCO2**, along with an elevated anion gap, not the respiratory alkalosis seen here. *Anxiety attack* - An **anxiety attack** causes acute **hyperventilation**, leading to **acute respiratory alkalosis** (high pH, low pCO2). - However, in an acute setting, there is insufficient time for significant renal compensation, so the HCO3- would remain near normal, unlike the compensated state shown in the panel.
Explanation: ***Xerostomia*** - The patient is experiencing an **acute angle-closure glaucoma (AACG) attack**, precipitated by **phenylephrine**, an alpha-1 adrenergic agonist causing pupillary dilation. - The systemic pharmacotherapy for AACG includes **acetazolamide**, a carbonic anhydrase inhibitor, to reduce aqueous humor production. - **Xerostomia** (dry mouth) is one of the **most common and immediately noticeable side effects** of acetazolamide, making it the most likely symptom the patient will experience. - Other common side effects include paresthesias (tingling in fingers/toes) and altered taste. *Epithelial keratopathy* - While ocular surface changes can occur in AACG due to elevated intraocular pressure, **epithelial keratopathy** specifically refers to corneal epithelial damage. - This is not a side effect of the systemic pharmacotherapy (acetazolamide) but rather a potential complication of the disease itself. - It is more commonly associated with conditions like dry eye or corneal exposure. *Metabolic acidosis* - Carbonic anhydrase inhibitors like acetazolamide **commonly cause non-anion gap metabolic acidosis** (type 2 renal tubular acidosis) by inhibiting carbonic anhydrase in the renal proximal tubules, impairing bicarbonate reabsorption. - However, this typically develops over hours to days and is often **asymptomatic or minimally symptomatic** in the acute setting. - While metabolic acidosis is a well-recognized side effect, **xerostomia is more immediately noticeable** to the patient, making it the better answer to "most likely to occur." *Bradycardia* - Beta-blockers (e.g., timolol) may be used **topically** for glaucoma management, but systemic absorption from topical drops is minimal. - The primary initial **systemic** treatment for AACG is acetazolamide, which does not cause bradycardia. - Bradycardia would be a concern if systemic beta-blockers were used, but this is not standard for acute management. *Diaphoresis* - Sweating (**diaphoresis**) is not a recognized side effect of acetazolamide or other medications typically used for acute angle-closure glaucoma. - The patient may experience diaphoresis from pain and nausea related to the acute glaucoma itself, but not from the pharmacotherapy.
Explanation: ***↓ ↑ ↓*** - S cells secrete **secretin**, which primarily inhibits **gastric acid (H+) secretion** to protect the duodenal mucosa from acidic chyme. - Secretin also stimulates the pancreas and bile ducts to secrete **bicarbonate (HCO3-)**, neutralizing the acidic chyme. Duodenal **chloride (Cl-) secretion is typically reduced** as it is often exchanged for bicarbonate or water follows bicarbonate secretion for osmotic balance. *↓ ↓ ↓* - While **gastric H+ decreases** due to secretin, **duodenal HCO3- secretion increases**, not decreases, making this option incorrect. - **Duodenal Cl- secretion** would likely decrease, but the other components are inconsistent with secretin's effects. *↑ ↓ no change* - Secretin **inhibits gastric H+ secretion**, so an increase contradicts its primary function to protect the duodenum from acid. - **Duodenal HCO3- secretion increases**, not decreases, and no change in Cl- is unlikely given the physiological responses to secretin. *↑ ↑ ↓* - Secretin **inhibits gastric H+ secretion**, so an increase is incorrect. - While **duodenal HCO3- increases** and **Cl- decreases**, the initial change in gastric H+ makes this option wrong. *↓ no change no change* - While **gastric H+ is indeed decreased**, secretin significantly **increases duodenal HCO3- secretion** and likely decreases duodenal Cl- secretion, making "no change" in these parameters incorrect. - Secretin has a pronounced effect on both bicarbonate and chloride transport in the duodenum.
Explanation: ***pH 7.57, PaO2 100, PCO2 23, HCO3 21*** - After 1 hour of strenuous exercise, this represents **respiratory alkalosis with mild metabolic compensation**, which is the expected finding in a healthy individual during sustained vigorous exercise. - The **low PCO2 (23 mmHg)** reflects appropriate **hyperventilation** in response to increased metabolic demands and lactic acid production. During intense exercise, minute ventilation increases dramatically, often exceeding the rate of CO2 production. - The **slightly elevated pH (7.57)** and **mildly decreased HCO3 (21 mEq/L)** indicate that respiratory compensation has slightly overshot, creating mild alkalosis, while the bicarbonate is consumed both in buffering lactate and through renal compensation. - **Normal PaO2 (100 mmHg)** confirms adequate oxygenation maintained by increased ventilation. *pH 7.36, PaO2 100, PCO2 40, HCO3 23* - These are **completely normal arterial blood gas values** with no evidence of any physiological stress or compensation. - After 1 hour of strenuous exercise, we would expect **hyperventilation with decreased PCO2**, not a normal PCO2 of 40 mmHg. This profile would be consistent with rest, not vigorous exercise. - The absence of any respiratory or metabolic changes makes this inconsistent with the clinical scenario. *pH 7.56, PaO2 100, PCO2 44, HCO3 38* - This profile suggests **metabolic alkalosis** (high pH, high HCO3) with inadequate respiratory compensation (normal to slightly elevated PCO2). - This is **not consistent with strenuous exercise**, which produces metabolic acid (lactate), not metabolic base. The elevated HCO3 suggests vomiting, diuretic use, or other causes of metabolic alkalosis. *pH 7.32, PaO2 42, PCO2 50, HCO3 27* - This indicates **respiratory acidosis** (low pH, high PCO2) with **severe hypoxemia** (PaO2 42 mmHg). - During strenuous exercise, healthy individuals **increase ventilation** to enhance O2 delivery and remove CO2, so both hypoxemia and hypercapnia are unexpected and would suggest severe cardiopulmonary disease or hypoventilation. *pH 7.38, PaO2 100, PCO2 69, HCO3 42* - This demonstrates **compensated respiratory acidosis** (normal pH, markedly elevated PCO2 and HCO3). - The **very high PCO2 (69 mmHg)** indicates severe **hypoventilation**, which is the opposite of what occurs during exercise. This profile suggests chronic respiratory failure with metabolic compensation, such as in severe COPD.
Explanation: ***Hypoxia*** - The patient exhibits **metabolic acidosis** (pH 7.28, HCO3- 14.4 mEq/L) with **appropriate respiratory compensation** (pCO2 32 mm Hg using Winter's formula: expected pCO2 = 1.5 × 14.4 + 8 ± 2 = 29.6 ± 2). - The **pO2 of 74 mm Hg is significantly low** (normal range on room air: 80-100 mm Hg), indicating **hypoxemia** that leads to **tissue hypoxia** and **anaerobic metabolism**. - In the setting of **obesity (BMI 41.5)** and **immediate post-operative status** after laparoscopic surgery, multiple factors contribute to hypoxemia including **atelectasis, reduced functional residual capacity, pain limiting deep breathing, residual anesthetic effects, and pneumoperitoneum effects**. - Tissue hypoxia results in **lactic acidosis** (a high anion gap metabolic acidosis), which explains the acid-base disturbance. The **elevated BUN (31 mg/dL) with relatively normal creatinine** suggests prerenal azotemia from hypoperfusion, further supporting inadequate tissue oxygenation. - The **tachycardia (103/min)** represents a compensatory response to improve oxygen delivery to hypoxic tissues. *Vomiting* - Vomiting causes loss of **gastric HCl**, resulting in **hypochloremic metabolic ALKALOSIS** (elevated pH and HCO3-), not acidosis. - While this patient is vomiting, the acid-base status shows **acidosis**, which is the opposite of what vomiting typically causes. - The low **Cl- (98 mEq/L)** is consistent with some gastric acid loss, but the dominant acid-base disorder is metabolic acidosis from another cause. *Uremia* - **Uremia** causes high anion gap metabolic acidosis due to retention of organic acids and phosphates in renal failure. - While the **BUN is elevated (31 mg/dL)**, the **creatinine (1.1 mg/dL) is essentially normal**, especially for a patient with high muscle mass (130 kg). - The BUN elevation is more consistent with **prerenal azotemia** (dehydration/hypoperfusion) rather than intrinsic renal failure causing uremic acidosis. *Late dumping syndrome* - **Late dumping syndrome** occurs **1-3 hours after eating** and results from rapid carbohydrate absorption causing hyperinsulinemia and subsequent **reactive hypoglycemia**. - This patient's **glucose is normal (88 mg/dL)**, and symptoms began only **2 hours post-surgery** in the fasting state, not after a meal. - Late dumping does not cause metabolic acidosis. *Early dumping syndrome* - **Early dumping syndrome** occurs **10-30 minutes after eating** due to rapid gastric emptying of hyperosmolar contents into the small intestine, causing fluid shifts. - Symptoms include **cramping, diarrhea, vasomotor symptoms (flushing, palpitations, dizziness)**, not metabolic acidosis. - This patient has not yet eaten post-operatively, making dumping syndrome impossible.
Explanation: ***6.1 + log[15/(0.03*25)]*** - This formula correctly represents the Henderson-Hasselbalch equation for the bicarbonate buffer system: **pH = pKa + log([HCO3-]/[0.03 * PCO2])**. - Here, **pKa is 6.1**, **[HCO3-] is 15**, and **[0.03 * PCO2] is 0.03 * 25**, making this the appropriate calculation for pH. *15/6.1 + log[10/(0.03*25)]* - This formula incorrectly places the pKa in the denominator of the first term and introduces an arbitrary '10' in the numerator of the logarithmic term. - The **Henderson-Hasselbalch equation** dictates that pKa is added, not divided into, another component, and the logarithmic term should reflect the ratio of bicarbonate to carbonic acid. *10^6.1 + 15/0.03*25* - This option incorrectly uses an exponentiation of pKa and adds it to an unrelated fractional term, which does not correspond to the Henderson-Hasselbalch equation structure. - The formula for pH calculation is a sum of pKa and a logarithmic term, not an exponentiation and a simple fraction. *6.1 + log[0.03/15*25]* - This option incorrectly inverts the ratio within the logarithm, placing the carbonic acid component (0.03 * PCO2) in the numerator and bicarbonate in the denominator. - The correct Henderson-Hasselbalch equation requires the **bicarbonate concentration in the numerator** and the carbonic acid concentration in the denominator. *6.1 + log [25/(15*0.03)]* - This option incorrectly places the PCO2 (25) in the numerator of the logarithmic term and the product of HCO3- and 0.03 in the denominator. - The correct ratio for the Henderson-Hasselbalch equation is **[HCO3-] / [0.03 * PCO2]**.
Explanation: ***Respiratory alkalosis*** - The patient's pH of **7.52** indicates alkalemia. A **PaCO2 of 28 mm Hg** (normal range 35-45 mm Hg) is low, indicating a respiratory component. - The **primary disturbance is respiratory alkalosis** due to hyperventilation from pneumonia/sepsis causing tachypnea and increased CO2 elimination. - The HCO3- of 21 mEq/L (normal range 22-26 mEq/L) is at the lower limit of normal. In acute respiratory alkalosis, bicarbonate remains near normal since **metabolic compensation takes 2-3 days** to develop significantly. - With a 3-day history, minimal renal compensation is expected, consistent with the near-normal bicarbonate. *Metabolic acidosis* - Metabolic acidosis would present with a **low pH** and a **low HCO3-**, which is not seen here. - The patient's pH is **alkaline (7.52)**, not acidic, ruling out this diagnosis. *Respiratory acidosis* - Respiratory acidosis would be characterized by a **low pH** and a **high PaCO2**, indicating hypoventilation. - The patient's **PaCO2 is low (28 mm Hg)** and the **pH is high**, directly contradicting respiratory acidosis. *Normal acid-base status* - A normal acid-base status would have a **pH between 7.35 and 7.45** and PaCO2 between 35-45 mm Hg. - The patient's **pH of 7.52** and **PaCO2 of 28 mm Hg** are both abnormal, specifically indicating alkalemia and hypocapnia. *Metabolic alkalosis* - Metabolic alkalosis would feature a **high pH** and a **high HCO3-** (typically >26 mEq/L), often resulting from conditions like vomiting or diuretic use. - While the patient is on hydrochlorothiazide, his **HCO3- is 21 mEq/L** (low-normal, not elevated), indicating this is not a primary metabolic alkalosis.
Explanation: ***Increase gastric acid secretion*** - The patient's history of a prolactinoma, family history of parathyroid adenoma, and current symptoms suggest **Multiple Endocrine Neoplasia type 1 (MEN1)**. - **MEN1** often involves **pancreatic neuroendocrine tumors**, specifically **gastrinomas**, which autonomously secrete **gastrin**, leading to **Zollinger-Ellison syndrome (ZES)**. - **Gastrin's primary function** is to stimulate **parietal cells** in the gastric mucosa to secrete **hydrochloric acid (HCl)**, leading to **massive gastric acid hypersecretion**. - This acid hypersecretion causes **severe peptic ulcer disease** (explaining the epigastric pain), **refractory ulcers**, and often **diarrhea** from acid overload in the small intestine. *Promote gastric mucosal growth* - While gastrin does have a **trophic effect** on gastric mucosa (promoting mucosal growth), this is a **secondary/chronic effect**, not the primary pathophysiologic mechanism. - The acute symptoms (epigastric pain, ulcers, weight loss) are directly caused by **acid hypersecretion**, not mucosal growth. - In clinical practice, the focus in Zollinger-Ellison syndrome is on managing the **acid hypersecretion** with high-dose proton pump inhibitors. *Increase pancreatic bicarbonate secretion* - **Secretin** is the primary hormone responsible for increasing pancreatic bicarbonate secretion in response to duodenal acidification. - Gastrin does not significantly affect pancreatic bicarbonate secretion. *Decrease gastrin secretion* - This is incorrect; the problem in gastrinomas is **autonomous hypersecretion of gastrin**. - Normally, low gastric pH inhibits gastrin release via negative feedback, but gastrinomas secrete gastrin autonomously, independent of feedback mechanisms. *Increase pancreatic exocrine secretion* - **Cholecystokinin (CCK)** is the primary hormone that stimulates pancreatic enzyme secretion. - While the excessive acid entering the duodenum in ZES may indirectly stimulate pancreatic secretion, gastrin itself does not directly increase pancreatic exocrine secretion significantly.
Explanation: ***Vitamin D deficiency*** - The patient's symptoms of **fatigue**, **muscle cramps**, **paresthesias** (tingling in hands), and **carpopedal spasm** (Trousseau's sign) are classic manifestations of **hypocalcemia**. - The **prolonged QT interval** on ECG further confirms hypocalcemia. - **Vitamin D deficiency** is the most common cause of hypocalcemia in elderly patients, especially those with: - **Chronic disease** (chronic bronchitis) - **Limited sun exposure** (likely given chronic illness) - **Poor nutrition** or malabsorption - **Normal alkaline phosphatase** (55 U/L) helps rule out severe bone disease - This is the most likely diagnosis given the clinical presentation and demographic factors. *Multiple endocrine neoplasia* - **MEN syndromes** (MEN1, MEN2a) typically cause **primary hyperparathyroidism** with **hypercalcemia**, not hypocalcemia. - There is no evidence of other endocrine tumors or family history to suggest MEN. *Ectopic hormone production* - **Ectopic PTHrP production** (e.g., from squamous cell lung carcinoma) causes **hypercalcemia**, not hypocalcemia. - While the patient has smoking history and chronic cough, his presentation is clearly hypocalcemia. *Medication side effect* - The patient's current medications (**salbutamol**, **ibuprofen**, **ramipril**) are not commonly associated with symptomatic hypocalcemia. - None of these medications typically cause carpopedal spasm or prolonged QT interval from calcium disturbances. *Destruction of parathyroid glands* - **Hypoparathyroidism** from parathyroid destruction (surgical, autoimmune, or infiltrative) would cause hypocalcemia. - However, there is **no history** of neck surgery, radiation, or autoimmune disease. - Without such history, this is less likely than vitamin D deficiency in an elderly patient with chronic disease.
Explanation: ***Decreased oxygen delivery to tissues*** - The patient's presentation in a running car in a garage suggests **carbon monoxide (CO) poisoning**. CO binds to hemoglobin with higher affinity than oxygen, forming **carboxyhemoglobin (COHb)**, which impairs oxygen delivery to tissues despite normal PaO2. - The **metabolic acidosis (pH 7.20, HCO3 10)** with an elevated anion gap (Na - (Cl + HCO3) = 137 - (96 + 10) = 31) and altered mental status are consistent with widespread tissue hypoxia due to decreased oxygen delivery, leading to **lactic acid accumulation**. *Decreased ability for the tissues to use oxygen* - This scenario typically occurs in conditions like **cyanide poisoning**, where cellular metabolism is inhibited, preventing oxygen utilization despite adequate delivery. - Cyanide poisoning often presents with a narrower or normal anion gap metabolic acidosis and a **"cherry red" skin color**, which are not specifically noted here. *Increased anions from toxic ingestion* - While there is an **elevated anion gap metabolic acidosis**, merely stating "increased anions from toxic ingestion" is less precise than identifying the underlying mechanism of oxygen deprivation. - Many toxins can cause an elevated anion gap, but the specific context of **CO poisoning** points to tissue hypoxia as the primary driver of acidosis, not just the presence of other toxic anions. *Increased metabolic rate* - An increased metabolic rate, as seen in conditions like **sepsis** or hyperthyroidism, can lead to increased acid production and metabolic acidosis. - However, in this case, the **depressed respiratory rate** and context of CO exposure point away from a primary state of hypermetabolism. *Decreased minute ventilation* - **Decreased minute ventilation** would primarily lead to **respiratory acidosis** (elevated PaCO2) due to CO2 retention. - The patient's lab results show a **low PaCO2 (23 mmHg)**, indicating respiratory compensation for a metabolic acidosis, not a primary respiratory problem.
Explanation: ***Increased release of secretin from S cells of the duodenum*** - A meal rich in **meat** (protein and fat) leads to gastric emptying of **acidic chyme** into the duodenum. - The resulting **low duodenal pH** stimulates the S cells to release **secretin**, which in turn stimulates **bicarbonate secretion** from the pancreas to neutralize the acid. *Increased release of ghrelin from P/D1 cells of the stomach* - **Ghrelin** is a **hunger-stimulating hormone** released when the stomach is empty, promoting food intake. - After a large meal, the stomach is full, leading to **decreased ghrelin release**, promoting satiety. *Decreased cholecystokinin release from the I cells of the duodenum* - A meal rich in **fat and protein** stimulates the I cells in the duodenum to release **cholecystokinin (CCK)**. - CCK promotes **gallbladder contraction** (bile release for fat digestion) and **pancreatic enzyme secretion** for protein and fat breakdown, so its release would increase, not decrease. *Increased gastrin release leading to a decrease in proton secretion* - **Gastrin** release is typically **increased** by the presence of food (especially protein) in the stomach, and its primary action is to **increase proton (acid) secretion** from parietal cells. - Therefore, increased gastrin would lead to **increased**, not decreased, proton secretion. *Decreased Ach release from the vagus nerve* - The **vagus nerve** is typically activated by the sight, smell, and presence of food in the stomach, releasing **acetylcholine (ACh)**. - ACh stimulates various digestive processes, including **gastric acid secretion**, so its release would generally **increase** after a meal, not decrease.
Explanation: ***Increased serum H+*** - This patient's symptoms (history of **type I diabetes**, **respiratory distress** with deep, labored respirations (**Kussmaul breathing**), and **fruity breath odor**) are classic for **diabetic ketoacidosis (DKA)**. - DKA leads to the overproduction of **ketone bodies** (strong acids), which overwhelm the body's buffer systems, resulting in an accumulation of **hydrogen ions (H+)** in the blood and a decrease in serum pH (acidosis). - This is the **most direct and fundamental** laboratory finding in DKA. *Increased serum HCO3-* - In DKA, the excess H+ ions are buffered by **bicarbonate (HCO3-)**, leading to a **decrease** in serum HCO3- as it is consumed in the buffering process, not an increase. - An increased serum HCO3- would typically indicate a state of **metabolic alkalosis** or compensation for respiratory acidosis. *Decreased urine H+* - The kidneys attempt to compensate for the acidosis by actively excreting excess H+ ions into the urine to restore acid-base balance, meaning urine H+ would be **increased**, not decreased. - Decreased urine H+ would suggest less acid excretion, which is counterproductive in acidosis. *Increased urine HCO3-* - In acidosis, the kidneys typically **reabsorb** HCO3- to help buffer the blood and prevent further loss of this base. Therefore, urine HCO3- would be **decreased** or absent, not increased. - Increased urine HCO3- can occur in conditions like renal tubular acidosis (type II) or compensation for respiratory alkalosis. *Increased urine H2PO4-* - While the kidneys do increase the excretion of **titratable acids** like dihydrogen phosphate (H2PO4-) as a compensatory mechanism in acidosis, this is a **secondary response** rather than the primary laboratory abnormality. - The question asks what you would "**most expect**" to find - the direct measurement of **increased serum H+** (reflecting the primary metabolic derangement) is more fundamental and clinically significant than a compensatory urinary change.
Explanation: ***Diarrhea*** - The patient's **low bicarbonate (8 mEq/L)** indicates a metabolic acidosis, and the **low PaCO2 (20 mmHg)** with a pH of 7.25 suggests a partially compensated metabolic acidosis. - The **anion gap** is calculated as Na - (Cl + HCO3) = 138 - (121 + 8) = 9 mEq/L. A normal anion gap (8-12 mEq/L) metabolic acidosis with low bicarbonate and low PaCO2 strongly points towards **bicarbonate loss**, which is characteristic of severe diarrhea. *Vomiting* - **Vomiting** typically leads to loss of stomach acid, resulting in **metabolic alkalosis** (increased bicarbonate and pH), which is the opposite of the patient's presentation. - While vomiting can cause fluid loss, the acid-base disturbance it creates is inconsistent with the presented ABG values. *Hypoventilation* - **Hypoventilation** causes **respiratory acidosis** due to the retention of CO2, leading to an increased PaCO2 and decreased pH. - This patient has a **low PaCO2**, indicating hyperventilation as a compensatory response, not hypoventilation as the primary problem. *Altitude sickness* - At **high altitudes**, the reduced partial pressure of oxygen leads to **hypoxia**, which stimulates hyperventilation. - This causes **respiratory alkalosis** (decreased PaCO2, increased pH), which is inconsistent with the metabolic acidosis seen here. *Ethanol consumption* - While chronic **heavy alcohol use** can lead to various metabolic derangements, including **alcoholic ketoacidosis**, this would present as a **high anion gap metabolic acidosis**. - The patient's **normal anion gap** (9 mEq/L) makes this an unlikely cause for his immediate acid-base disturbance.
Explanation: ***pH 7.51, PaCO2 50, serum chloride 81 mEq/L, serum bicarbonate 38 mEq/L*** - This patient presents with **incessant vomiting**, leading to significant loss of **gastric acid** (HCl). This loss causes **metabolic alkalosis**, characterized by an **elevated pH (7.51)** and **high bicarbonate (38 mEq/L)**. The relative hypoventilation (high PaCO2) is a **compensatory mechanism** for the alkalosis. - The **low serum chloride (81 mEq/L)** is also consistent with the loss of stomach acid. *pH 7.31, PaCO2 30, serum chloride 92 mEq/L, serum bicarbonate 15 mEq/L* - This indicates **metabolic acidosis** (low pH, low bicarbonate), which would typically be seen in conditions like **diabetic ketoacidosis** or **lactic acidosis**, not profuse vomiting. - The low PaCO2 suggests **respiratory compensation** for acidosis, which contradicts the clinical picture of vomiting. *pH 7.39, PaCO2 37, serum chloride 102 mEq/L, serum bicarbonate 27 mEq/L* - These values are within the **normal range** for pH, PaCO2, and bicarbonate, indicating no significant acid-base disturbance. - This does not align with the patient's symptoms of intractable nausea and vomiting, which would cause an acid-base imbalance. *pH 7.36, PaCO2 75, serum chloride 119 mEq/L, serum bicarbonate 42 mEq/L* - This suggests **respiratory acidosis** (high PaCO2) with a **metabolic alkalosis** (high bicarbonate). - While metabolic alkalosis can result from vomiting, the severe respiratory acidosis is not explained by the clinical scenario. *pH 7.46, PaCO2 26, serum chloride 102 mEq/L, serum bicarbonate 16 mEq/L* - This indicates **respiratory alkalosis** (high pH, low PaCO2) with a **metabolic acidosis** (low bicarbonate). - This pattern is seen in conditions like **hyperventilation** or early sepsis, which is inconsistent with recurrent vomiting.
Explanation: ***Urine chloride*** - The patient presents with **metabolic alkalosis** (pH 7.58, HCO3- 32 mEq/L with minimal respiratory compensation). - **Urine chloride** is the key diagnostic test to differentiate between **saline-responsive** (urine Cl <20 mEq/L) and **saline-unresponsive** (urine Cl >20 mEq/L) metabolic alkalosis. - Given the patient's **4-day history of vomiting**, this is likely saline-responsive alkalosis from gastric HCl loss, which would be confirmed by low urine chloride and guide appropriate treatment with saline repletion. *Serum anion gap* - The **serum anion gap** is primarily used to evaluate causes of **metabolic acidosis** (differentiating high AG from normal AG acidosis). - It would not provide useful information for determining the etiology of metabolic alkalosis. *Urine albumin to creatinine ratio* - The **urine albumin to creatinine ratio** screens for **kidney damage** or **proteinuria**. - There is no clinical indication (e.g., elevated creatinine, edema, hypertension) to suggest kidney disease as the cause of her acid-base imbalance. *Serum osmolal gap* - The **serum osmolal gap** detects **exogenous osmotically active substances** like toxic alcohols (methanol, ethylene glycol) or mannitol. - These typically cause **high anion gap metabolic acidosis**, not metabolic alkalosis, making this test inappropriate for this patient. *Urine anion gap* - The **urine anion gap** differentiates causes of **normal anion gap metabolic acidosis** by assessing urinary ammonium excretion (positive in RTA, negative in GI losses). - It is not indicated for the evaluation of metabolic alkalosis.
Explanation: ***Metabolic acidosis complicated by respiratory acidosis*** - The patient's pH is significantly low (7.12), indicating **acidemia**. The **HCO3- is markedly low (12 mEq/L)**, and PCO2 is elevated (60 mm Hg), suggesting both a metabolic and a respiratory component to the acidosis. - The severe infection (fever, elevated heart rate, hypotension, flank pain, leukocytosis, elevated creatinine) and the signs of hypoperfusion contribute to **lactic acidosis (metabolic acidosis)**, while his history of COPD and lung findings (decreased breath sounds, wheezes, crackles) explain the impaired ventilation leading to **respiratory acidosis**. *Metabolic acidosis complicated by respiratory alkalosis* - While a **metabolic acidosis** is clearly present due to the low pH and HCO3-, the PCO2 is elevated, indicating **respiratory acidosis**, not alkalosis. - Respiratory alkalosis would be characterized by a **low PCO2** due to hyperventilation. *Non-anion gap metabolic acidosis* - To determine the anion gap, we use the formula: **Na+ - (Cl- + HCO3-)**. In this case, 140 - (102 + 12) = 140 - 114 = **26 mEq/L**. - An anion gap of 26 mEq/L, which is significantly elevated (normal range is typically 8-12 mEq/L), indicates an **anion gap metabolic acidosis**, not a non-anion gap one. *Respiratory alkalosis complicated by metabolic acidosis* - The low pH and HCO3- confirm **metabolic acidosis**, but the elevated PCO2 (60 mm Hg) indicates **respiratory acidosis**, not alkalosis, as the respiratory component is also acidotic. - Respiratory alkalosis would result from **hyperventilation and a low PCO2**. *Respiratory acidosis complicated by metabolic alkalosis* - While the elevated PCO2 indicates **respiratory acidosis**, the HCO3- is significantly low (12 mEq/L), which points to a **metabolic acidosis**, not metabolic alkalosis. - **Metabolic alkalosis** would be characterized by an **elevated HCO3-**.
Explanation: ***Anxiety-induced hyperventilation*** - The patient's **pH of 7.54** and **low PCO2 of 23 mm Hg** indicate **respiratory alkalosis**, a condition where the body expels too much CO2. - Hyperventilation, often triggered by **anxiety or acute pain**, leads to excessive CO2 exhalation, causing the blood to become more alkaline. *Renal failure-induced electrolyte imbalance* - **Renal failure** typically leads to **metabolic acidosis** due to the kidney's inability to excrete acid or reabsorb bicarbonate, which would result in a low pH, not a high one. - The patient's basic electrolyte levels and bicarbonate are within normal limits (aside from the pH imbalance), making renal failure unlikely to be the cause of her elevated pH. *Weight loss-induced electrolyte imbalance* - Rapid or significant **weight loss** might affect electrolyte levels (e.g., potassium), but it does not directly cause **respiratory alkalosis** or a primary elevation in pH. - Her blood gas results specifically point to a respiratory cause for the alkalosis. *Pain-induced hypoventilation* - **Hypoventilation** means reduced breathing, which would lead to **CO2 retention** and thus **respiratory acidosis** (a decrease in pH), not alkalosis. - While the patient is in severe pain, her breathing rate of 26 breaths/min indicates tachypnea, not hypoventilation. *Alcohol-induced respiratory depression* - **Alcohol intoxication** can cause **respiratory depression**, leading to reduced breathing, which results in **CO2 retention** and thus **respiratory acidosis** (low pH). - Her elevated pH and low PCO2 clearly rule out respiratory depression as the cause of her acid-base disturbance.
Explanation: ***pH: increased, HCO3-: decreased, Pco2: decreased*** - The patient's presentation with **agitation**, **dizziness**, **paresthesias** (tingling in lips and hands), and **tachypnea** (respiratory rate 25/min) is highly suggestive of **hyperventilation** due to an anxiety attack. - **Hyperventilation** leads to excessive **CO2 expulsion**, causing a decrease in Pco2, which results in respiratory alkalosis (increased pH) and a compensatory decrease in HCO3-. *pH: increased, HCO3-: increased, Pco2: increased* - An **increased pH** coupled with **increased HCO3-** and **increased Pco2** would suggest a **metabolic alkalosis with respiratory compensation**, which is not consistent with the patient's acute hyperventilation. - While pH is increased, the other values contradict the primary respiratory cause suggested by the symptoms. *pH: decreased, HCO3-: decreased, Pco2: decreased* - This profile describes **metabolic acidosis with respiratory compensation**, which would typically present with **Kussmaul breathing** and other signs of acidosis, not acute hyperventilation and agitation. - Symptoms such as dizziness and tingling are associated with alkalosis, not acidosis. *pH: decreased, HCO3-: increased, Pco2: increased* - This pattern is characteristic of **respiratory acidosis with metabolic compensation**, often seen in conditions like **COPD exacerbation** or **opioid overdose** with hypoventilation. - The patient's rapid breathing and clinical picture are not consistent with respiratory acidosis. *pH: normal, HCO3-: increased, Pco2: increased* - A **normal pH** with **increased HCO3-** and **increased Pco2** would indicate a **compensated metabolic alkalosis**. - Her acute symptoms point to an uncompensated or acutely compensated respiratory disorder, not a compensated metabolic issue.
Explanation: ***Decreased serum ionized calcium concentration*** - The patient presents with **circumoral numbness** and **muscle twitching** (consistent with tetany), and a positive **Trousseau's sign** (painful contractions of hand muscles with blood pressure cuff inflation). These are classic signs of **hypocalcemia**. - The **arterial blood gas** shows **respiratory alkalosis** (elevated pH 7.53, decreased pCO2 29 mm Hg). In alkalosis, more calcium binds to albumin, causing a **decrease in ionized (free) calcium** even when total calcium is normal. It is the ionized calcium that is physiologically active and responsible for neuromuscular function. - The **decreased ionized calcium** directly causes the tetany and neuromuscular irritability observed in this patient. *Increased serum potassium concentration* - **Hyperkalemia** typically presents with muscle weakness, fatigue, and cardiac arrhythmias, not tetany or circumoral numbness. - The symptoms described are not characteristic of high potassium levels. *Increased serum phosphate concentration* - **Hyperphosphatemia** can lead to decreased serum calcium due to the formation of calcium-phosphate complexes, but it is not the primary direct cause of the symptoms in the setting of acute respiratory alkalosis. - Furthermore, hyperphosphatemia itself does not directly cause muscle twitching or circumoral numbness as a primary effect. *Increased peripheral oxygen unloading from hemoglobin* - **Increased oxygen unloading** from hemoglobin (a right shift of the oxygen dissociation curve) is typically associated with acidosis, fever, or increased 2,3-BPG. - **Alkalosis** (as seen in this patient) causes a **left shift** of the oxygen dissociation curve, leading to **decreased oxygen unloading** in the periphery. *Decreased cerebral blood flow* - **Hyperventilation** causes **respiratory alkalosis**, which in turn leads to **cerebral vasoconstriction** and therefore **decreased cerebral blood flow**. - While this is a true physiological consequence of the patient's hyperventilation, it does not directly explain the **tetany** and **circumoral numbness** (which are due to decreased ionized calcium). The neuromuscular symptoms are specifically caused by hypocalcemia, making ionized calcium the most relevant additional finding.
Explanation: ***Respiratory acidosis*** - The **pH (7.32)** is acidic (normal 7.35-7.45), and the **pCO2 (70 mmHg)** is significantly elevated (normal 35-45 mmHg), indicating **primary respiratory acidosis** due to hypoventilation. - The **bicarbonate (30 mEq/L)** is elevated above normal (22-26 mEq/L), indicating **partial metabolic compensation** by the kidneys retaining bicarbonate to buffer the acidosis. - This pattern suggests **chronic respiratory acidosis** (e.g., from COPD, CNS depression, neuromuscular disease) with renal compensation. *Metabolic alkalosis* - This would present with **elevated pH** (>7.45) and **elevated bicarbonate** as the primary disturbance, often with compensatory elevation in pCO2. - The patient's **pH is acidic (7.32)**, not alkalotic, ruling out metabolic alkalosis as the primary process. *Respiratory alkalosis* - This would present with **elevated pH** (>7.45) and **decreased pCO2** (<35 mmHg) due to hyperventilation. - The patient has the opposite: **acidic pH and elevated pCO2**, ruling out respiratory alkalosis. *Metabolic acidosis* - This would present with **decreased pH** and **decreased bicarbonate** (<22 mEq/L) as the primary disturbance. - While the pH is low, the **bicarbonate is elevated (30 mEq/L)**, not decreased, ruling out metabolic acidosis as the primary disorder. *Mixed alkalosis* - A mixed alkalosis would involve simultaneous respiratory and metabolic processes causing **elevated pH**. - The patient's **pH is acidic (7.32)**, making any form of alkalosis impossible as the primary disturbance.
Explanation: ***Decreased urinary bicarbonate excretion*** - The patient's ABG results (pH 7.33, PCO2 53 mmHg) indicate **chronic respiratory acidosis**, consistent with a **COPD exacerbation** on a background of chronic disease. - In chronic respiratory acidosis, the kidneys compensate by **retaining bicarbonate** (increasing reabsorption) and **excreting hydrogen ions** to normalize pH. - Therefore, urinary bicarbonate excretion is **decreased** as the kidneys conserve bicarbonate to buffer the chronic acidosis. *Decreased urinary chloride concentration* - This is typically seen in states of **metabolic alkalosis** (with volume contraction) or profound **volume depletion**, neither of which is the primary condition here. - The patient has respiratory acidosis, not metabolic alkalosis. *Increased serum anion gap* - An increased anion gap indicates **metabolic acidosis** due to accumulation of unmeasured anions (e.g., lactate, ketones, toxins). - The patient has **respiratory acidosis**, not metabolic acidosis with an anion gap. - The anion gap is not directly affected by primary respiratory disorders. *Increased urine osmolar gap* - An increased urine osmolar gap suggests the presence of **unmeasured osmolytes** in the urine (e.g., from methanol or ethylene glycol ingestion). - There is nothing in the patient's presentation to suggest toxic ingestion. *Increased urinary pH* - Increased urinary pH would occur if the kidneys were **excreting bicarbonate**, which happens in metabolic alkalosis or renal tubular acidosis. - In chronic respiratory acidosis, the kidneys compensate by **excreting acid** (lowering urinary pH) and **retaining bicarbonate**. - Therefore, urinary pH would be **decreased**, not increased.
Explanation: ***Bicarbonate secretion*** - The symptoms of pain relieved by food intake and an ulcer in the **duodenal bulb** are classic for a **duodenal ulcer** - Duodenal ulcers are often due to an imbalance between protective factors and aggressive factors in the duodenum; hyperplasia of submucosal glandular structures, specifically **Brunner's glands**, represents an attempt to increase **bicarbonate secretion** and protect against acid - Brunner's glands secrete alkaline mucus rich in bicarbonate to neutralize gastric acid entering the duodenum, which is a key protective mechanism *Antigen presentation* - **Antigen presentation** is primarily a function of immune cells (e.g., macrophages, dendritic cells) and is not directly related to the function of Brunner's glands or the pathogenesis of duodenal ulcers - While immune cells are present in the gastrointestinal tract, the hyperplasia described is not linked to an increase in antigen presentation *Glycoprotein synthesis* - While **mucosal cells** in the gastrointestinal tract do synthesize glycoproteins (e.g., mucins) for protection, the hyperplasia of **submucosal glandular structures** (Brunner's glands) is specifically associated with bicarbonate and mucin secretion, with **bicarbonate being the primary protective mechanism** - An increase in glycoprotein synthesis, while part of mucosal defense, is not the most direct or primary consequence of Brunner's gland hyperplasia as a compensatory mechanism for duodenal ulcers *Hydrochloric acid secretion* - **Hydrochloric acid (HCl)** is secreted by **parietal cells** in the stomach, not by glands in the duodenum - An increase in HCl secretion would worsen a duodenal ulcer, not be a protective response *Lysozyme secretion* - **Lysozyme** is an enzyme with antimicrobial properties found in various secretions (e.g., tears, saliva, phagocytes) and some glandular cells in the intestines (e.g., Paneth cells) - While it plays a role in innate immunity, it is not the primary secretion associated with the protective function of **Brunner's glands** in response to duodenal ulcers
Explanation: ***pH: 7.30, PaCO2: 15 mmHg, HCO3-: 16 mEq/L*** - This blood gas analysis shows a **low pH** (acidemia), **low PaCO2** (hypocapnia), and **low HCO3-** (bicarbonate). This pattern is consistent with a **primary metabolic acidosis** with a **compensatory respiratory alkalosis**. - In this clinical scenario, the patient likely has **salicylate toxicity** (aspirin poisoning). Salicylate toxicity initially causes respiratory alkalosis due to direct stimulation of the respiratory center, followed by a high anion gap metabolic acidosis as salicylates interfere with cellular metabolism. This specific ABG reflects a mixed disorder where metabolic acidosis is predominant and respiratory compensation is attempting to raise the pH. The **tinnitus** and **confusion** are classic symptoms of salicylate toxicity. *pH: 7.37, PaCO2: 41 mmHg, HCO3-: 12 mEq/L* - This blood gas shows a **normal pH**, **normal PaCO2**, and **low HCO3-**. This suggests a **compensated metabolic acidosis**, where the body has fully compensated to bring the pH back to normal. - While the patient likely has metabolic acidosis from salicylate toxicity, full compensation to a normal pH is less characteristic of an acute, severe presentation with significant neurological symptoms. *pH: 7.41, PaCO2: 65 mmHg, HCO3-: 34 mEq/L* - This blood gas shows a **normal pH**, **high PaCO2**, and **high HCO3-**. This indicates a **compensated respiratory acidosis**, where the kidneys have compensated for chronic CO2 retention. - This pattern is not consistent with salicylate toxicity, which typically causes **respiratory alkalosis** early on, and later **metabolic acidosis**. *pH: 7.47, PaCO2: 11 mmHg, HCO3-: 24 mEq/L* - This blood gas analysis shows a **high pH** (alkalemia), **very low PaCO2** (severe hypocapnia), and a **normal HCO3-**. This indicates a **primary respiratory alkalosis** with no significant metabolic compensation. - While salicylate toxicity can cause respiratory alkalosis, severe confusion and the progression of symptoms suggest a more advanced stage, usually involving a metabolic acidosis component, making a pure, uncompensated respiratory alkalosis less likely. *pH: 7.31, PaCO2: 31 mmHg, HCO3-: 15 mEq/L* - This blood gas shows a **low pH**, **low PaCO2**, and **low HCO3-**. This also indicates a **metabolic acidosis** with **respiratory compensation**. - However, compared to pH 7.30, PaCO2 15 mmHg, and HCO3- 16 mEq/L, this option shows slightly **less severe respiratory compensation** (PaCO2 is higher), which is less typical for the profound respiratory stimulation seen in severe salicylate poisoning. The chosen correct option demonstrates a more characteristic and maximal respiratory compensation for the degree of metabolic acidosis.
Explanation: ***Vomiting*** - The superficial mucosal tear in the distal esophagus ("Mallory-Weiss tear") is strongly associated with **forceful vomiting**, which can lead to significant loss of gastric acid. - Loss of gastric acid (HCl) through vomiting causes a **metabolic alkalosis** as hydrogen ions are excreted, and the kidneys compensate by retaining bicarbonate. *Hepatic cirrhosis* - While common in alcoholics, **hepatic cirrhosis** typically leads to **metabolic acidosis** due to impaired lactate metabolism and renal dysfunction, rather than alkalosis. - It would not directly explain the acute esophageal tear or the direct cause of metabolic alkalosis seen here. *Hypokalemia* - **Hypokalemia** can result from vomiting and can perpetuate metabolic alkalosis, but it is a consequence or a contributing factor, not the primary mechanism of acid-base disturbance. - The initial loss of acid through vomiting is the direct cause of the alkalosis, which then often leads to compensatory hypokalemia. *B12 deficiency* - **B12 deficiency** is common in alcoholics but primarily causes **macrocytic anemia** and neurological symptoms, not metabolic alkalosis or esophageal tears. - It has no direct physiological link to acid-base balance in a way that would cause metabolic alkalosis. *Anemia* - **Anemia** can be caused by chronic alcoholism or blood loss from the esophageal tear, but it does not directly lead to **metabolic alkalosis**. - While blood loss can have various systemic effects, it does not involve the loss of gastric acid that defines a vomiting-induced alkalosis.
Buffer systems (bicarbonate, phosphate, protein)
Practice Questions
Henderson-Hasselbalch equation
Practice Questions
Renal regulation of acid-base balance
Practice Questions
Renal bicarbonate handling
Practice Questions
Ammonia production and excretion
Practice Questions
Titratable acid excretion
Practice Questions
Respiratory regulation of acid-base
Practice Questions
Metabolic acidosis mechanisms and compensation
Practice Questions
Metabolic alkalosis mechanisms and compensation
Practice Questions
Respiratory acidosis mechanisms and compensation
Practice Questions
Respiratory alkalosis mechanisms and compensation
Practice Questions
Mixed acid-base disorders
Practice Questions
Clinical approach to acid-base disorders
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free